All lobbying filings
Infusion Providers Alliance
Infusion Providers Alliance filed a Q1 report for Infusion Providers Alliance on April 21, 2025.
Lobbying for Infusion Providers Alliance
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$30,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Lobbyists on this filing
1
-
BRAD TRAVERSE New on this filingPreviously held: Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs
Government bodies contacted
4
Lobbying activity
2
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.
Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.
Bills named in this filing
1